Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleORIGINAL ARTICLE

Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ Channel

Jiesheng Kang, Xiao-Liang Chen, Hongge Wang, Junzhi Ji, Hsien Cheng, Josephine Incardona, William Reynolds, Fabrice Viviani, Michel Tabart and David Rampe
Molecular Pharmacology March 2005, 67 (3) 827-836; DOI: https://doi.org/10.1124/mol.104.006577
Jiesheng Kang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Liang Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongge Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junzhi Ji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsien Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josephine Incardona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Reynolds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrice Viviani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Tabart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Rampe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 67 no. 3 827-836
DOI 
https://doi.org/10.1124/mol.104.006577
PubMed 
15548764

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 24, 2004
  • Accepted November 17, 2004
  • Published online February 16, 2005.

Article Versions

  • Earlier version (November 17, 2004 - 14:09).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jiesheng Kang,
  2. Xiao-Liang Chen,
  3. Hongge Wang,
  4. Junzhi Ji,
  5. Hsien Cheng,
  6. Josephine Incardona,
  7. William Reynolds,
  8. Fabrice Viviani,
  9. Michel Tabart and
  10. David Rampe
  1. Departments of Medicinal Chemistry (M.T.) and Oncology (F.V.) Aventis Pharmaceuticals, Vitry-Sur-Seine, France; and Department of Drug Safety Evaluation, Aventis Pharmaceuticals, Bridgewater, New Jersey (J.K., X.-L.C., H.W., J.J., H.C., J.I., W.R., D.R.)
  1. Address correspondence to:
    Dr. David Rampe, Aventis Pharmaceuticals, Inc., Route 202–206, Building JR2-2236, Bridgewater, NJ 08807-0800. E-mail: david.rampe{at}aventis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2004 to May 2022

AbstractFullPdf
Nov 2004440171
Dec 2004310137
Jan 200536099
Feb 200513670104
Mar 200590105138
Apr 2005246966
May 2005357160
Jun 2005316165
Jul 2005245331
Aug 2005244539
Sep 2005123126
Oct 200593220
Nov 2005255327
Dec 2005253925
Jan 2006142024
Feb 2006261018
Mar 2006134340
Apr 200684028
May 2006224244
Jun 2006153946
Jul 2006232930
Aug 200684127
Sep 2006142218
Oct 200692727
Nov 2006152928
Dec 2006482921
Jan 200792931
Feb 2007163730
Mar 200772729
Apr 2007112117
May 200793127
Jun 200761814
Jul 200741114
Aug 200781820
Sep 2007131725
Oct 200793125
Nov 2007122520
Dec 200781822
Jan 2008122434
Feb 2008121412
Mar 2008183327
Apr 2008162724
May 2008142319
Jun 2008202617
Jul 2008132019
Aug 20087178
Sep 2008142417
Oct 200811169
Nov 2008101818
Dec 200891012
Jan 2009111214
Feb 2009141512
Mar 2009171111
Apr 2009161814
May 2009101215
Jun 2009162115
Jul 200991618
Aug 200911910
Sep 2009211214
Oct 200913818
Nov 2009101417
Dec 2009181016
Jan 201013816
Feb 2010131017
Mar 2010191712
Apr 2010121613
May 201022119
Jun 2010261121
Jul 2010191714
Aug 2010121410
Sep 2010986
Oct 2010182021
Nov 2010163422
Dec 2010122312
Jan 20111578
Feb 2011222912
Mar 2011201923
Apr 2011161414
May 2011251620
Jun 2011181412
Jul 201113917
Aug 2011161514
Sep 2011132511
Oct 2011142910
Nov 2011333224
Dec 2011212014
Jan 201228157
Feb 2012191213
Mar 2012171119
Apr 2012171113
May 2012191512
Jun 2012202516
Jul 2012201414
Aug 2012201216
Sep 2012181419
Oct 2012251620
Nov 2012332320
Dec 2012232613
Jan 2013362617
Feb 2013271510
Mar 2013391440
Apr 2013171611
May 2013171111
Jun 20131647
Jul 201313115
Aug 20131995
Sep 20131034
Oct 201310822
Nov 20132357
Dec 2013698
Jan 201412126
Feb 2014161113
Mar 20148915
Apr 201415105
May 20141437
Jun 20141664
Jul 20141589
Aug 20145109
Sep 2014131210
Oct 201412144
Nov 2014191713
Dec 201417137
Jan 20151788
Feb 2015171245
Mar 201516146
Apr 2015252114
May 2015281619
Jun 2015151810
Jul 2015293922
Aug 201532228
Sep 20151173
Oct 201552510
Nov 20159125
Dec 2015121310
Jan 2016202217
Feb 2016181412
Mar 201613127
Apr 201621710
May 201619138
Jun 201692214
Jul 2016132213
Aug 201625179
Sep 201616168
Oct 201692914
Nov 201673915
Dec 20168293
Jan 20171254
Feb 201712010
Mar 201742815
Apr 20171347
May 20170244
Jun 20171211
Jul 20171266
Aug 20170282
Sep 20170221
Oct 20170364
Nov 20170463
Dec 201713610
Jan 20180367
Feb 20181363
Mar 201823911
Apr 201833110
May 20180386
Jun 20182353
Jul 20180239
Aug 20180344
Sep 20180929
Oct 201816011
Nov 201806210
Dec 20185784
Jan 201946117
Feb 20193332
Mar 20192744
Apr 201919127
May 20193823
Jun 20192027
Jul 20191245
Aug 20191933
Sep 20192544
Oct 20191442
Nov 20193143
Dec 20192173
Jan 20201144
Feb 20204183
Mar 20201844
Apr 2020825
May 20201453
Jun 202036512
Jul 20201121
Aug 2020633
Sep 20202421
Oct 20201563
Nov 20201322
Dec 202011105
Jan 202112297
Feb 202112225
Mar 20213031
Apr 20212341
May 202138134
Jun 202119152
Jul 20212226
Aug 202115202
Sep 20211040
Oct 20211571
Nov 20211086
Dec 20212821
Jan 20223631
Feb 2022931
Mar 2022811
Apr 20222442
May 20221985

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 67 (3)
Molecular Pharmacology
Vol. 67, Issue 3
1 Mar 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ Channel
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleORIGINAL ARTICLE

Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ Channel

Jiesheng Kang, Xiao-Liang Chen, Hongge Wang, Junzhi Ji, Hsien Cheng, Josephine Incardona, William Reynolds, Fabrice Viviani, Michel Tabart and David Rampe
Molecular Pharmacology March 1, 2005, 67 (3) 827-836; DOI: https://doi.org/10.1124/mol.104.006577

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleORIGINAL ARTICLE

Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ Channel

Jiesheng Kang, Xiao-Liang Chen, Hongge Wang, Junzhi Ji, Hsien Cheng, Josephine Incardona, William Reynolds, Fabrice Viviani, Michel Tabart and David Rampe
Molecular Pharmacology March 1, 2005, 67 (3) 827-836; DOI: https://doi.org/10.1124/mol.104.006577
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics